We hypothesized that overnight treatment with PAM3CSK4, a TLR2 agonist, would stimulate BMMs and increase MG levels, affecting infection dynamics of ΔgloA L. monocytogenes that are impaired for MG detoxification. The gene discussed is TLR2; the disease is infection.